RKRozhan Khezri

Rozhan Khezri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rozhan Khezri has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Educational inequalities in neonatal outcomes: a multilevel analysis of a multicenter retrospective cohort study

    by Rozhan Khezri, Najmeh Zarei Jelyani, Reza Mosaddegh, Sara Nikafarin, Neda Hashemi, Shayesteh Jahanfar, Fatemeh Rezaei

  • Open Access

    The Effect of Story Therapy on Reducing Anxiety in Children with Cancer Undergoing Chemotherapy

    by Afsaneh Ehtesham, Maryam Homayounpour, Ghasem Miri-Aliabadi, Marzieh Talebi Tadi, Zohre Moeini, Alireza Eshghi, Rozhan Khezri, Neda Ashayeri

    Background: Childhood cancer, a major cause of mortality, causes significant psychological stress in young patients, negatively impacting their quality of life and potentially interfering with treatment. Objectives: This study aimed to evaluate the effectiveness of storytelling as an intervention to reduce anxiety in children undergoing chemotherapy for cancer. Patients and Methods: This randomized clinical trial, conducted from January to November 2023 at Ali Asghar Children's Hospital in Tehran, involved forty children undergoing chemotherapy. Forty children were randomly allocated to either the intervention group (n = 20) or the control group (n = 20) using block randomization. The intervention group participated in ten weekly 1.5-hour storytelling sessions, while the control group received standard care without additional intervention. Anxiety levels were assessed using the Revised Children's Manifest Anxiety Scale (RCMAS) alongside a researcher-developed checklist. Assessments were conducted at baseline and after the completion of the ten storytelling sessions to measure outcomes. Data were analyzed using the Kolmogorov-Smirnov test to assess normality and the independent t-test to compare group differences. Results: Independent t-test results showed that before the intervention, the story therapy group had significantly higher total anxiety scores (17.12 ± 2.06) compared to the control group (12.20 ± 5.27; P = 0.002). After the intervention, the story therapy group exhibited significantly lower total anxiety scores (9.76 ± 3.73) than the control group (15.97 ± 4.14; P < 0.001). Post-intervention analysis revealed significant reductions in physiological anxiety (2.41 vs. 5.50, P < 0.001), concentration anxiety (3.53 vs. 6.00, P = 0.001), and total anxiety (9.76 vs. 15.95, P < 0.001) in the story therapy group compared to the control group, while worry scores did not show a significant difference (3.82 vs. 4.45, P = 0.301). Gender comparisons indicated significant decreases in physiological and total anxiety for both men and women following story therapy, although concentration anxiety improved significantly only in men. Age-based analyses revealed that younger children (≤ 7 years) had higher initial physiological, concentration, and total anxiety scores but experienced more significant reductions after intervention than older children, with worry scores remaining unchanged across ages. Conclusions: The findings suggest that storytelling can be used as a valuable and non-invasive treatment method to reduce anxiety in children with cancer.

  • Barriers to engagement in non-communicable disease prevention and public health care programs in Iran: A qualitative study

    by Najmeh Zarei Jelyani, Ebtesam Savari, Saina Jahanian, Saeedeh Askari, Mozhgan Maddahi, Tayebeh Najafimoghadam, Faranak Rahimi Beiranvand, Rozhan Khezri


  • Top Cited Papers
    Open Access

    Association between maternal anemia during pregnancy with low birth weight their infants

    by Rozhan Khezri, Fatemeh Rezaei, Shayesteh Jahanfar, Kamran Ebrahimi

    Low birth weight and anemia are significant public health challenges in developing countries. This study seeks to evaluate the relationship between hemoglobin levels during the first and second trimesters of pregnancy and the occurrence of low birth weight, while accounting for potential confounding factors. This multi-center cross-sectional study was conducted among all pregnant women with COVID-19 and with no history of receiving the COVID-19 vaccine who delivered in public and private hospitals in three counties, Mahabad, Miandoab, Bukan in Iran, using routinely collected maternity and health data on pregnancies. Hemoglobulin levels were measured during the first (6–10th weeks) and second (24–28th weeks) trimesters of pregnancy, and pregnancy outcomes were recorded in the health information system. Hb levels were categorized into four groups as follows: ≥110 g/L, 100–109 g/L, 90–99 g/L, and < 90 g/L for the first trimester and ≥ 105 g/L, 100–104 g/L, 90–99 g/L, and < 90 g/L for the second trimester. Multivariable logistic regression analysis determined the association between hemoglobin levels during pregnancy and low birth weight. P-values < 0.05 were considered statistically significant. A total of 385 mothers with COVID-19 were included. The mean age of COVID-19 pregnant women was 30.01 ± 6.24 years. After multivariable adjustment, Hb levels < 110 g/L in the first trimester had a significant association with low birth weight [OR, 4.13; (95% CI 2.11–8.10)]. Morevoer, Hb levels < 105 g/L in the second trimester was a significant association with low birth weight [OR:3.91; (95% CI:1.98–7.75)]. Maternal anemia during pregnancy, including first and second trimesters, was a significant association with Low birth weight even after adjusting for common confounders. Effective management and monitoring of anemia in pregnant women, particularly in low- and middle-income countries, are crucial for preventing low birth weight.


  • Open Access

    Rising Monkeypox Cases and Decreased Smallpox Immunity Raise Concerns of Potential Pandemic

    by Monireh Faghir Ganji, Sepideh Jahanian, Rozhan Khezri

    Monkeypox can spread rapidly among humans. Over 10,000 new Monkeypox virus(MPV) cases were reported between May 4 and July 12, 2022. It is transmitted through contact with infected animals, respiratory droplets, and shared items. Symptoms are similar to smallpox but milder. Smallpox is caused by variola virus (VAV). The halt in ...


  • Open Access

    Severe COVID-19 and Its Related Factors in Pregnant Women: A Multi-Center Cross‐Sectional Study

    by Rozhan Khezri, Fatemeh Rezaei, Sepideh Jahanian, Kamran Ebrahimi

    Background & Aims: Pregnant women are at a higher risk of contracting COVID-19 due to their weakened immune systems. There are various related factors for severe COVID-19 in pregnant women. This study aimed to assess the severe COVID-19 rate and its associated factors among Iranian pregnant women. Materials & Methods: In ...


  • Open Access

    The importance of differentiating monkeypox from chickenpox: possible response for better preparedness

    by Rozhan Khezri, Fatemeh Rezaei, Sepideh Jahanian, Mojgan ZareiVenovel

    Dear Editor-in-Chief Monkeypox is a global public health concern that needs serious attention to prevent it from spreading worldwide and encountering a new pandemic like COVID-19 again. Since the 1970s, monkeypox has been endemic in several African countries, but the biggest outbreak of monkeypox started in May 2022 in non-endemic countries (1). ...


  • Open Access

    Lessons learned about virtual education during the COVID-19 pandemic

    by Monireh Faghir-Gangi, Rozhan Khezri, Yousef Mohammadpour, Rohollah Valizadeh


  • Open Access

    Laboratory-based versus non-laboratory-based World Health Organization risk equations for assessment of cardiovascular disease risk

    by Azizallah Dehghan, Ali Rayatinejad, Rozhan Khezri, Dagfinn Aune, Fatemeh Rezaei

    Background: The WHO model has laboratory-based and non-laboratory-based versions for 10-year risk prediction of cardiovascular diseases. Due to the fact that in some settings, there may not be the necessary facilities for risk assessment with a laboratory-based model, the present study aimed to determine the agreement between laboratory-based and non-laboratory-based WHO cardiovascular risk equations. Methods: In this cross-sectional study, we used the baseline data of 6796 individuals without a history of cardiovascular disease and stroke who participated in the Fasa cohort study. The risk factors of the laboratory-based model included age, sex, systolic blood pressure (SBP), diabetes, smoking and total cholesterol, while the non-laboratory-based model included age, sex, SBP, smoking and BMI. Kappa coefficients was used to determine the agreement between the grouped risk and Bland–Altman plots were used to determine the agreement between the scores of the two models. Sensitivity and specificity of non-laboratory-based model were measured at the high-risk threshold. Results: In the whole population, the agreement between the grouped risk of the two models was substantial (percent agreement = 79.0%, kappa = 0.68). The agreement was better in males than in females. A substantial agreement was observed in all males (percent agreement = 79.8%, kappa = 0.70) and males < 60 years old (percent agreement = 79.9%, kappa = 0.67). The agreement in males ≥ 60 years old was moderate (percent agreement = 79.7%, kappa = 0.59). The agreement among females was also substantial (percent agreement = 78.3%, kappa = 0.66). The agreement for females < 60 years old, (percent agreement = 78.8%, kappa = 0.61) was substantial and for females ≥ 60 years old, (percent agreement = 75.8%, kappa = 0.46) was moderate. According to Bland–Altman plots, the limit of agreement was (95%CI: -4.2% to 4.3%) for males and (95%CI: -4.1% to 4.6%) for females. The range of agreement was suitable for both males < 60 years (95%CI: -3.8% to 4.0%) and females < 60 years (95%CI: -3.6% to 3.9%). However, it was not suitable for males ≥ 60 years (95% CI: -5.8% to 5.5%) and females ≥ 60 years (95%CI: -5.7% to 7.4%). At the high-risk threshold of 20% in non-laboratory and laboratory-based models, the sensitivity of the non-laboratory-based model was 25.7%, 70.7%, 35.7%, and 35.4% for males < 60 years, males ≥ 60 years, females < 60 years, and females ≥ 60 years, respectively. At the high-risk threshold of 10% in non-laboratory-based and 20% in laboratory-based models, the non-laboratory model has high sensitivity of 100% for males ≥ 60 years, females < 60 years, females ≥ 60 years, and 91.4% for males < 60 years. Conclusion: A good agreement was observed between laboratory-based and non-laboratory-based versions of the WHO risk model. Also, at the risk threshold of 10% to detect high-risk individuals, the non-laboratory-based model has acceptable sensitivity for practical risk assessment and the screening programs in settings where resources are limited and people do not have access to laboratory tests.


  • Open Access

    The association between maternal anemia during pregnancy and preterm birth

    by Rozhan Khezri, Shaker Salarilak, Sepideh Jahanian